Corgenix signs CMO deal with EDP Biotech

Diagnostics outfit Corgenix is upping its stake in the contract manufacturing game, inking a deal with EDP Biotech to produce a colon cancer test. Under the 10-year deal, Corgenix will manufacture ColoMarker, EDP's blood test for early stage colon cancer. The agreement follows Corgenix's May expansion of its contract services business, an effort to pad revenue and capitalize on the increase in demand for in vitro diagnostics. More